NCT01890213View on ClinicalTrials.gov

Immunotherapy With CEA(6D) VRP Vaccine (AVX701) in Patients With Stage III Colorectal Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

June 30, 2017

Study Completion Date

July 31, 2019

Conditions
Stage III Colon Cancer
Interventions
BIOLOGICAL

AVX701

Trial Locations (1)

27710

Duke University Medical Center, Durham

Sponsors

Lead Sponsor

Duke University

Collaborators (1)

AlphaVax, Inc.
All Listed Sponsors
collaborator

AlphaVax, Inc.

INDUSTRY

lead

Duke University

OTHER

NCT01890213 - Immunotherapy With CEA(6D) VRP Vaccine (AVX701) in Patients With Stage III Colorectal Cancer | Biotech Hunter | Biotech Hunter